MedPath

A CLINICAL TRAIL TO STUDY THE ANALGESIC EFFICACY OF ORAL CLONIDINE VS INTRATHECAL CLONIDINE WHEN ADDED AS AN ADJUVANT TO 0.5% HYPERBARIC BUPIVACAINE IN CESAREAN SECTION.

Phase 1
Not yet recruiting
Conditions
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium,
Registration Number
CTRI/2021/08/035730
Lead Sponsor
Dr Vignesh T M
Brief Summary

This study is a randomized single centre trial comparing the effect of Intrathecal clonidine vs oral clonidine when added as an adjuvant to 0.5% hyperbaric bupivacaine in patients undergoing cesarean section, that will be conducted in a single centre in india. The primary objective is to measure the duration of analgesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • ASA physical status â… and â…¡.
  • Age 18-31 years.
  • Singleton pregnancy Informed, written and valid consent.
Exclusion Criteria
  • Obstetric complications such as Placenta previa, Abruptio placenta and Preeclampsia.
  • Spinal deformity such as kyphoscoliosis.
  • BMI greater than 35kg/m2.
  • Height less than 150 cm or greater than180 cm.
  • Women with Hypertensive disorders,Cardiovascular disorders,Deep vein thrombosis.
  • Allergy to study drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the duration of analgesia.Duration of analgesia is assessed every 15 minutes from onset of sensory block to first request for rescue analgesic or VAS score 4 or more.
Secondary Outcome Measures
NameTimeMethod
Onset and duration of sensory block.Onset and duration of motor block.

Trial Locations

Locations (1)

Karnataka institute of medical sciences

🇮🇳

Dharwad, KARNATAKA, India

Karnataka institute of medical sciences
🇮🇳Dharwad, KARNATAKA, India
Dr Vignesh T M
Principal investigator
9524567167
vickyvijay1995@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.